4Boulton AJ.The diabetic foot:a global view[J].Diabetes Metab Res Rev,2000,16(Suppl 1):S1-S5.
5Zheng ZJ,Sharrettb AR,Chamblessc LE,et al.Associa-tions of ankle-brachial index with clinical coronary heart disease,stroke and preclinical carotid and popliteal atherosclerosis:the Atherosclerosis Risk in Communities (ARIC) Study[J].Atherosclerosis,1997,131(1):115-125.
6Danesh J,Collins R,Peto R.Lipoprotein(a) and coron-ary heart disease.Meta-analysis of prospective studies[J].Circulation,2000,102(10):1082-1085.
7Craig WY,Bostom AG.Lipoprotein(a) concentration and risk of atherothrombotic disease[J].JAMA,1995,274(15):1198-1199.
8Topciu Shufta V,Begolli L,Kryeziu E.Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis[J].Bosn J Basic Med Sci,2010,10(1):19-25.
9Guo M,Sahni SK,Sahni A,et al.Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells[J].Thromb Haemost,2004,92(4):858-866.
